RxDoctor Payments DataLook up a doctor →

Eric Teller, MD

Critical Care Medicine · Hackensack, NJNPI 1700097326

Payments from drug & device makers

$216,605in general payments, 2019–2025

Across 1,593 payments — averaging $135.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$127K
  • Sanofi$35K
  • Regeneron Healthcare Solutions, Inc.$21K
  • GSK$13K
  • Idorsia Pharmaceuticals US Inc$5K
  • Amgen$2K
  • plus $13K from 36 others

What the payments were for

  • Consulting fees$4,3672%
  • Speaking & faculty fees$176,75382%
  • Travel & lodging$4,1032%
  • Food & beverage$29,87914%
  • Education$1,5041%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$216,605 in reported general payments places this provider in the 95th percentile of 254 critical care medicine providers in New Jersey.

See all critical care medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$170,026
Medicare patients
637
Services billed
1,476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tyvaso DpiTreprostinil11$282,410
Trelegy ElliptaFluticasone/Umeclidin/Vilanter309$277,117
OfevNintedanib Esylate20$253,850
OpsumitMacitentan13$164,161
Dupixent PenDupilumab21$74,624
Breztri AerosphereBudesonide/Glycopyr/Formoterol85$63,476
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr103$63,208
Spiriva RespimatTiotropium Bromide81$63,154
Breo ElliptaFluticasone/Vilanterol79$38,126
Incruse ElliptaUmeclidinium Bromide84$33,798
SymbicortBudesonide/Formoterol Fumarate46$15,612
Advair HfaFluticasone Propion/Salmeterol25$15,443
Spiriva HandihalerTiotropium Bromide22$15,010
Arnuity ElliptaFluticasone Furoate48$14,295
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$13,718

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta$12,774$426,544623 claims
Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat$2,120$341,140130 claims
Actelion Pharmaceuticals US, Inc.Opsumit$543$164,16113 claims
AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler$127,413$85,101146 claims
Idorsia Pharmaceuticals US IncQuviviq$4,955$6,54914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 254 critical care medicine providers in New Jersey.

Other critical care medicine in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →